Literature DB >> 18427727

Headaches related to triptans therapy in patients of migrainous vertigo.

Sanjay Prakash1, Bhavana V Chavda, Hiren Mandalia, Rishi Dhawan, Deepak Padmanabhan.   

Abstract

Dizziness and vertigo are frequently reported by patients with migraine. In migrainous vertigo (MV), vertigo is causally related to migraine. Patients of MV usually have an attenuated or absent headache with their vertigo as compared with their usual headache of migraine. Here we report three female patients of MV in which administration of triptan was associated with induction (two patients) or exacerbation (one patient) of headache with disappearance of vertigo. We suggest that headache and vertigo of migraine may be inversely related to each other and suppression of one may induce or aggravate the other.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427727      PMCID: PMC3476202          DOI: 10.1007/s10194-008-0035-9

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  13 in total

1.  Episodic vertigo and migraine.

Authors:  R W Evans; R W Baloh
Journal:  Headache       Date:  2001-06       Impact factor: 5.887

2.  Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles.

Authors:  A Elhusseiny; E Hamel
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors.

Authors:  Rami Burstein; Moshe Jakubowski; Dan Levy
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

4.  Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients.

Authors:  Enrico Marano; Vincenzo Marcelli; Emanuela Di Stasio; Salvatore Bonuso; Giovanni Vacca; Fiore Manganelli; Elio Marciano; Anna Perretti
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

5.  How caloric vestibular irritation influences migraine attacks.

Authors:  O Kolev
Journal:  Cephalalgia       Date:  1990-08       Impact factor: 6.292

6.  Migrainous vertigo: prevalence and impact on quality of life.

Authors:  H K Neuhauser; A Radtke; M von Brevern; M Feldmann; F Lezius; T Ziese; T Lempert
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

7.  CNS effects of sumatriptan and rizatriptan in healthy female volunteers.

Authors:  J van der Post; M T Schram; R C Schoemaker; M S M Pieters; E Fuseau; A Pereira; S Baggen; A F Cohen; J M A van Gerven
Journal:  Cephalalgia       Date:  2002-05       Impact factor: 6.292

Review 8.  Vertigo and dizziness related to migraine: a diagnostic challenge.

Authors:  H Neuhauser; T Lempert
Journal:  Cephalalgia       Date:  2004-02       Impact factor: 6.292

Review 9.  Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.

Authors:  D W Dodick; V Martin
Journal:  Cephalalgia       Date:  2004-06       Impact factor: 6.292

10.  Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine.

Authors:  Vlasta Vuković; Davor Plavec; Ivana Galinović; Arijana Lovrencić-Huzjan; Mislav Budisić; Vida Demarin
Journal:  Headache       Date:  2007 Nov-Dec       Impact factor: 5.887

View more
  2 in total

1.  Central Integration of Canal and Otolith Signals is Abnormal in Vestibular Migraine: A Commentary.

Authors:  Marcelo M Valença
Journal:  Front Neurol       Date:  2015-01-06       Impact factor: 4.003

2.  A pilot study of rizatriptan and visually-induced motion sickness in migraineurs.

Authors:  Joseph M Furman; Dawn A Marcus
Journal:  Int J Med Sci       Date:  2009-08-06       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.